Reference Epigenome Mapping Centers (U01)

The summary for the Reference Epigenome Mapping Centers (U01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Reference Epigenome Mapping Centers (U01): The National Institutes of Health invites applications for Reference Epigenome Mapping Centers (REMCs) to develop comprehensive reference epigenomes from human embryonic stem cells (hESC), human differentiating and differentiated cells, cell lines and tissues. A total of $10 million for each of 5 years has been committed, beginning in FY2008. The anticipated number of awards is 3-5. The U01 Cooperative Agreement award mechanism will be used. Eligible organizations include Public/State Controlled Institution of Higher Education, Private Institution of Higher Education, Nonprofit with 501(c)(3) IRS Status (Other than Institution of Higher Education), Nonprofit without 501(c)(3) IRS Status (Other than Institution of Higher Education), Small Business, For-Profit Organization (Other than Small Business), State Government, U.S. Territory or Possession, Indian/Native American Tribal Government (Federally Recognized), Indian/Native American Tribal Government (Other than Federally Recognized), Indian/Native American Tribally Designated Organization Eligible Center Directors include any individual with the skills, knowledge, experience and resources necessary to carry out the proposed research. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support. More than one Center Director/Principal Investigator (CD/PI), or multiple CDs/PIs, may be designated on this application. Applicants may submit more than one application, provided they are scientifically distinct.

Federal Grant Title:	Reference Epigenome Mapping Centers (U01)
Federal Agency Name:	National Institutes of Health
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-RM-07-013
Type of Funding:	Cooperative Agreement
CFDA Numbers:	93.310
CFDA Descriptions:	Trans-NIH Research Support
Current Application Deadline:	No deadline provided
Original Application Deadline:	Mar 07, 2008
Posted Date:	Nov 15, 2007
Creation Date:	Nov 15, 2007
Archive Date:	Apr 07, 2008
Total Program Funding:	$10,000,000
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: Others (see text field entitled "Additional Information on Eligibility" for clarification) Native American tribal governments (Federally recognized) Special district governments Small businesses City or township governments For profit organizations other than small businesses Native American tribal organizations (other than Federally recognized tribal governments) Public housing authorities/Indian housing authorities Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education County governments Independent school districts State governments Public and State controlled institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Additional Information on Eligibility: Foreign institutions are not eligible to apply. Domestic applicants are encouraged to form multi-institute consortia to accomplish the stated goals. Applications from foreign institutions are not allowed. However, domestic institutions may include a foreign component, provided the majority of the research projects are based at the domestic institution.
Link to Full Grant Announcement: Information not provided
Grant Announcement Contact: NIH OER Webmaster
[email protected]
[email protected] If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants: • Pilot Projects Enhancing Utility and Usage of Common Fund Data Sets (R03 Clinical Trial No...; • Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allow...; • NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional); • NIH Directors Early Independence Awards (DP5 Clinical Trial Optional); • NIH Directors New Innovator Award Program (DP2 Clinical Trial Optional); • Using Metabolomics to Investigate Biological Pathways and Networks (R01); • Assay Development for High Throughput Molecular Screening (R21); • Membrane Protein Production and Structure Determination (R01)
More Grants from the National Institutes of Health: • SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies...; • Small Business Transition Grant For Early Career Scientists (R41/R42 Clinical Trial Not Al...; • Cystic Fibrosis Research and Translation Centers (P30 Clinical Trial Optional); • Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial No...; • Mentored Quantitative Research Development Award (Parent K25 Independent Basic Experimenta...